Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSL2101261 | ASC22注射液 | envafolimab | Injection | Biological Products(1) | New Drug Application | 2021-08-13 | Ascletis Biological Technology(Hangzhou) Co Ltd | view | |||
CXSL1900120 | ASC22 | envafolimab | Injection | Biological Products(1) | New Drug Application | 2019-11-01 | 歌礼生物科技(杭州)有限公司 | Ascletis Biological Technology(Hangzhou) Co Ltd | In Review | 2019-10-31 | view |